SPECIAL FEATURES:
Email
In lab, drug-on-the-cob fights rare disease
Scientists have made a medical enzyme using genetically-engineered corn, a feat that could slash the cost life-threatening inherited disease treatment.
Tue, Sep 18 2012 at 1:02 PM
Related Topics:
Inserting a section of DNA code into maize seed caused them to make alpha-L-iduronidase in the endosperm, a nutritive tissue in the corn kernel. Alpha-L-iduronidase breaks down sugar molecules and is deficient in people with mucopolysaccheridosis I. (Phot
Biologists in Canada have made a medical enzyme using genetically-engineered corn, a feat that could one day slash the cost of treating a life-threatening inherited disease, a journal reported on Tuesday.
Inserting a section of DNA code into maize seed caused them to make alpha-L-iduronidase in the endosperm, a nutritive tissue in the corn kernel.
Alpha-L-iduronidase breaks down sugar molecules and is deficient in people with mucopolysaccheridosis I.
This is a so-called lysosomal storage disorder, in which sugary debris builds up in cells, damaging tissue in the heart, eyes, skeleton and brain.
Without replacement enzymes, sufferers of MPS 1 often die in childhood.
Until now, the therapy has been produced by coaxing cultures of cells taken from the ovaries of Chinese hamsters, and is hugely expensive.
The existing drug for MPS 1, laronidase (marketed as Aldurazyme) costs around $300,000 annually for children and $1 million for adults.
The research, led by Allison Kermode at Simon Fraser University in Burnaby, British Columbia, is published in the journal Nature Communications.
The results amount to "proof of concept" for making the enzyme in laboratory conditions, the team say.
Further work would be needed to scale up volume, but this should not be too much of a problem and conventional techniques could be used, they add.
Severe MPS I occurs in approximately in one in 100,000 newborns, according to the website Genetics Home Reference, which is supported by the US health authorities.
A milder form, called attenuated MPS I, occurs in about one in 500,000 births.
Copyright 2012 AFP Global Edition
You might also like:
Sign in with one of these accounts to add your comment.
EDITORS' PICKS
Advertisement
TODAY'S MOST POPULAR ON
- Student science experiment finds plants won't grow near Wi-Fi router
- 15 famous people who mysteriously disappeared
- 10 false facts most people think are true
- 9 habits that may do more harm than good
- World's oldest beehive discovered in ancient church
- 12 best new features of the Samsung Galaxy S4
- 13 natural remedies for the ant invasion
- 8 hair care treatments you can make yourself
- U.S. solider and stray cat save each other in Afghanistan
- The 9 nastiest things in your supermarket
From our sponsor
Follow us:
NEWSLETTER
Advertisement
Join the conversation